What Is the Typical Dosage of Ozempic for Weight Loss?

Last reviewed: June 19, 2026

Last updated: June 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic (semaglutide) is a GLP-1 receptor agonist originally developed for type 2 diabetes that has demonstrated significant weight reduction effects in clinical trials. The medication works through a structured dosing protocol that allows your body to adjust gradually while maximizing efficacy and tolerability. Understanding how semaglutide dosing progresses helps patients and providers make informed treatment decisions.

How Semaglutide Dosing Starts and Progresses

Semaglutide weight loss treatment begins with a low starting dose to minimize gastrointestinal side effects and allow metabolic adjustment. The standard initiation protocol uses 0.25 mg injected subcutaneously once weekly for the first month. This introductory phase establishes tolerance while your body begins responding to GLP-1 pathway activation.

After the initial four-week period, the dose increases to 0.5 mg weekly in month two. Each subsequent month typically adds another 0.25 mg increment until reaching 2.4 mg weekly, which represents the therapeutic dose most commonly used in weight management studies. This titration ladder usually requires 12 weeks total to reach full therapeutic dosing, though individual timelines vary based on tolerance and clinical response.

Standard Maintenance Dosage and Treatment Duration

The maintenance dose for semaglutide weight loss therapy is typically 2.4 mg administered as a single subcutaneous injection once per week. This dosage was selected based on clinical evidence showing optimal balance between weight reduction outcomes and side effect tolerability in large population studies. Most patients continue at this level as long as treatment benefits outweigh any adverse effects.

Treatment duration varies widely depending on individual goals, response patterns, and ongoing clinical monitoring. Some patients maintain semaglutide for 12 to 24 months, while others continue longer-term as part of comprehensive weight management plans. Your dosing timeline and maintenance level should be determined collaboratively between you and your prescribing provider based on your unique health profile and response metrics.

Factors That Influence Your Semaglutide Dosing Plan

Kidney function, liver health, and gastrointestinal tolerance directly impact how quickly your dose can increase and what maintenance level works best. Patients with certain medical conditions may require slower titration schedules or lower maximum doses to ensure safety. Your healthcare provider will assess these factors during initial evaluation and ongoing follow-up visits.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Cost and Access for Semaglutide at PlexusDx

PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with flat pricing across all dose levels—meaning your monthly cost remains the same whether you're taking 0.25 mg or 2.4 mg. This transparent pricing structure removes financial barriers to dose optimization and eliminates unexpected cost increases as your treatment progresses. No insurance is required, no membership fees apply, and HSA and FSA accounts are accepted.

All PlexusDx medications come from licensed 503A compounding pharmacies and are available to patients across all 50 states. After your first month of treatment, the optional Precision Peptide Genetic Test is available for $298 to further personalize your protocol. PlexusDx coordinates with your provider to ensure dosing adjustments align with your clinical progress and genetic insights.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical starting dose of semaglutide for weight loss?

The standard starting dose is 0.25 mg injected once weekly for the first four weeks. This low-dose initiation minimizes nausea and gastrointestinal upset while your body adjusts to GLP-1 activation. PlexusDx provides compounded semaglutide injections following this evidence-based titration schedule.

How long does it take to reach the full therapeutic dose?

Most patients reach the maintenance dose of 2.4 mg within 12 weeks using the standard escalation protocol, which increases by 0.25 mg every four weeks. Some individuals titrate more slowly based on tolerance, which may extend the timeline by several additional weeks. Your provider will adjust pace based on your response and side effect profile.

Will my PlexusDx cost increase if my semaglutide dose goes up?

No. PlexusDx compounded semaglutide injections maintain flat pricing at $189/mo (or $149/mo on the 6-month plan) regardless of your dose level. Your dose may need to go up, but your price won't—this transparent model eliminates surprise costs during treatment optimization.

What if I experience side effects at my current dose?

Dose reduction or slower titration is appropriate if gastrointestinal symptoms become intolerable. Nausea typically improves with time, dietary adjustments, and slower dose escalation. Your PlexusDx provider can modify your protocol and monitor your adjustment carefully to balance efficacy with comfort.

How does the Precision Peptide Genetic Test help with my dosing?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Glp 1 Dosage For Weight Loss
• Weight Loss Drugs Like Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.